112 related articles for article (PubMed ID: 25132665)
1. Highly active macromolecular prodrugs inhibit expression of the hepatitis C virus genome in the host cells.
Ruiz-Sanchis P; Wohl BM; Smith AA; Zuwala K; Melchjorsen J; Tolstrup M; Zelikin AN
Adv Healthc Mater; 2015 Jan; 4(1):65-8. PubMed ID: 25132665
[TBL] [Abstract][Full Text] [Related]
2. Macromolecular (pro)drugs with concurrent direct activity against the hepatitis C virus and inflammation.
Wohl BM; Smith AA; Jensen BE; Zelikin AN
J Control Release; 2014 Dec; 196():197-207. PubMed ID: 25451544
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a new phosphorylated ribavirin prodrug.
Dong SD; Lin CC; Schroeder M
Antiviral Res; 2013 Jul; 99(1):18-26. PubMed ID: 23624267
[TBL] [Abstract][Full Text] [Related]
4. Polyanionic Macromolecular Prodrugs of Ribavirin: Antiviral Agents with a Broad Spectrum of Activity.
Hinton TM; Zuwala K; Deffrasnes C; Todd S; Shi S; Marsh GA; Dearnley M; Wohl BM; Tolstrup M; Zelikin AN
Adv Healthc Mater; 2016 Mar; 5(5):534-40. PubMed ID: 26789641
[TBL] [Abstract][Full Text] [Related]
5. Macromolecular prodrugs of ribavirin: concerted efforts of the carrier and the drug.
Smith AA; Wohl BM; Kryger MB; Hedemann N; Guerrero-Sanchez C; Postma A; Zelikin AN
Adv Healthc Mater; 2014 Sep; 3(9):1404-7. PubMed ID: 24408515
[TBL] [Abstract][Full Text] [Related]
6. Narrow therapeutic window of ribavirin as an inhibitor of nitric oxide synthesis is broadened by macromolecular prodrugs.
Wohl BM; Smith AA; Kryger MB; Zelikin AN
Biomacromolecules; 2013 Nov; 14(11):3916-26. PubMed ID: 24156371
[TBL] [Abstract][Full Text] [Related]
7. Cyclic phosphoramidates as prodrugs of 2'-C-methylcytidine.
Meppen M; Pacini B; Bazzo R; Koch U; Leone JF; Koeplinger KA; Rowley M; Altamura S; Di Marco A; Fiore F; Giuliano C; Gonzalez-Paz O; Laufer R; Pucci V; Narjes F; Gardelli C
Eur J Med Chem; 2009 Sep; 44(9):3765-70. PubMed ID: 19493593
[TBL] [Abstract][Full Text] [Related]
8. Macromolecular Prodrugs of Ribavirin: Structure-Function Correlation as Inhibitors of Influenza Infectivity.
Riber CF; Hinton TM; Gajda P; Zuwala K; Tolstrup M; Stewart C; Zelikin AN
Mol Pharm; 2017 Jan; 14(1):234-241. PubMed ID: 28043136
[TBL] [Abstract][Full Text] [Related]
9. Cyclic monophosphate prodrugs of base-modified 2'-C-methyl ribonucleosides as potent inhibitors of hepatitis C virus RNA replication.
Gunic E; Girardet JL; Ramasamy K; Stoisavljevic-Petkov V; Chow S; Yeh LT; Hamatake RK; Raney A; Hong Z
Bioorg Med Chem Lett; 2007 May; 17(9):2452-5. PubMed ID: 17331721
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional aryloxyphosphoramidate prodrugs of 2'-C-Me-uridine: synthesis and anti-HCV activity.
Maiti M; Gao LJ; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
Org Biomol Chem; 2016 Sep; 14(37):8743-8757. PubMed ID: 27714209
[TBL] [Abstract][Full Text] [Related]
11. Prospects for hepatitis C virus therapeutics: levovirin and viramidine as improved derivatives of ribavirin.
Watson J
Curr Opin Investig Drugs; 2002 May; 3(5):680-3. PubMed ID: 12090539
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of stable isotope labeled analogs of the anti-hepatitis C virus nucleotide prodrugs PSI-7977 and PSI-352938.
Chun BK; Du J; Zhang HR; Chang W; Ross BS; Jiang Y; Bao D; Espiritu CL; Keilman M; Steuer HM; Furman PA; Sofia MJ
Nucleosides Nucleotides Nucleic Acids; 2011 Nov; 30(11):886-96. PubMed ID: 22060553
[TBL] [Abstract][Full Text] [Related]
13. Macromolecular prodrugs of ribavirin combat side effects and toxicity with no loss of activity of the drug.
Kryger MB; Wohl BM; Smith AA; Zelikin AN
Chem Commun (Camb); 2013 Apr; 49(26):2643-5. PubMed ID: 23431562
[TBL] [Abstract][Full Text] [Related]
14. Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin.
Derudas M; Brancale A; Naesens L; Neyts J; Balzarini J; McGuigan C
Bioorg Med Chem; 2010 Apr; 18(7):2748-55. PubMed ID: 20207546
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin analogs.
Shields WW; Pockros PJ
Clin Liver Dis; 2009 Aug; 13(3):419-27. PubMed ID: 19628158
[TBL] [Abstract][Full Text] [Related]
16. Taribavirin in the treatment of hepatitis C.
Deming P; Arora S
Expert Opin Investig Drugs; 2011 Oct; 20(10):1435-43. PubMed ID: 21854301
[TBL] [Abstract][Full Text] [Related]
17. Dual pro-drugs of 2'-C-methyl guanosine monophosphate as potent and selective inhibitors of hepatitis C virus.
McGuigan C; Madela K; Aljarah M; Gilles A; Battina SK; Ramamurty CV; Srinivas Rao C; Vernachio J; Hutchins J; Hall A; Kolykhalov A; Henson G; Chamberlain S
Bioorg Med Chem Lett; 2011 Oct; 21(19):6007-12. PubMed ID: 21856153
[TBL] [Abstract][Full Text] [Related]
18. β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship study.
Du J; Bao D; Chun BK; Jiang Y; Reddy PG; Zhang HR; Ross BS; Bansal S; Bao H; Espiritu C; Lam AM; Murakami E; Niu C; Micolochick Steuer HM; Furman PA; Otto MJ; Sofia MJ
Bioorg Med Chem Lett; 2012 Sep; 22(18):5924-9. PubMed ID: 22892115
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and evaluation of liver-specific gemcitabine prodrugs for potential treatment of hepatitis C virus infection and hepatocellular carcinoma.
Stephenson AA; Cao S; Taggart DJ; Vyavahare VP; Suo Z
Eur J Med Chem; 2021 Mar; 213():113135. PubMed ID: 33454548
[TBL] [Abstract][Full Text] [Related]
20. Current and future use of nucleo(s)tide prodrugs in the treatment of hepatitis C virus infection.
Dousson CB
Antivir Chem Chemother; 2018; 26():2040206618756430. PubMed ID: 29463095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
